Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nampt inhibitor FK-866 inhibits lung tumor cell growth in vitro

May 28, 2008

Responses to romidepsin seen in phase II cutaneous T-cell lymphoma study

May 27, 2008

Panobinostat active against poorly differentiated and anaplastic thyroid carcinoma cells

May 26, 2008

GTx phase III toremifene trial continues after interim efficacy analysis

May 26, 2008

Recent patents impart novel treatment options for cancer

May 26, 2008

Antitumor effects of chemotherapy enhanced by inhibition of N-cadherin

May 26, 2008

Encouraging phase I interim data reported for CG-0070 in bladder cancer

May 23, 2008

Bayer Yakuhin obtains additional indication approval in Japan for Fludara

May 23, 2008

Ariad initiates phase I trial of AP-24534 in patients with hematological cancers

May 23, 2008

Global clinical SIR-Spheres microspheres trial launched in colorectal cancer

May 23, 2008

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...